Related Experiment Video
Updated: Sep 7, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.2K
Multimodal deep learning for Alzheimer's disease dementia assessment
Shangran Qiu1,2, Matthew I Miller1, Prajakta S Joshi3,4,5
1Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
Nature Communications
|June 20, 2022
Summary
A new deep learning framework aids in diagnosing dementia, including Alzheimer's disease (AD) and mild cognitive impairment (MCI). This AI tool analyzes clinical data to identify cognitive conditions, improving diagnostic accuracy.
Area of Science:
- Neurology
- Artificial Intelligence
- Medical Diagnostics
Background:
- Dementia affects millions globally, with Alzheimer's disease (AD) being the most prevalent form.
- Accurate diagnosis of cognitive impairment is crucial for timely intervention and management.
- Current diagnostic methods can be complex and require specialized expertise.
Purpose of the Study:
- To develop and validate a deep learning framework for the multi-step diagnosis of cognitive impairment.
- To identify individuals with normal cognition (NC), mild cognitive impairment (MCI), AD, and non-AD dementias (nADD).
- To assess the diagnostic accuracy of the framework compared to clinical experts.
Main Methods:
- A deep learning framework was designed to process diverse clinical data, including demographics, medical history, and functional assessments.
- Models were trained to distinguish between NC, MCI, AD, and nADD.
- Interpretability methods were used to visualize brain patterns identified by the models.
Main Results:
- The deep learning framework demonstrated diagnostic accuracy comparable to practicing neurologists and neuroradiologists.
- Models successfully integrated various data types, including clinical information and neuroimaging.
- Interpretable AI revealed disease-specific patterns correlating with neuropathological changes.
Conclusions:
- Deep learning offers a promising approach to enhance the diagnosis of dementia and related cognitive disorders.
- The framework's ability to analyze multimodal data and achieve expert-level accuracy supports its clinical utility.
- AI-driven diagnostic tools can provide valuable insights into the underlying neuropathology of cognitive impairment.
Related Concept Videos
Alzheimer's Disease: Overview
664
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
664
Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
Dementia
165
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
165

